Cryo-Cell International I...

NASDAQ: CCEL · Real-Time Price · USD
4.11
-0.44 (-9.67%)
At close: Aug 14, 2025, 3:29 PM
4.33
5.35%
Pre-market: Aug 15, 2025, 07:01 AM EDT

Cryo-Cell International Income Statement

Financials in USD. Fiscal year is December - November.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Nov 30, 2024 Nov 30, 2023 Nov 30, 2022 Nov 30, 2021
Revenue
31.99M 31.34M 30.34M 28.88M
Cost of Revenue
7.95M 8.44M 8.79M 8.99M
Gross Profit
24.04M 22.9M 21.54M 19.9M
Operating Income
3.48M -12.3M 4.02M 4M
Interest Income
n/a n/a n/a n/a
Pretax Income
2.8M -13.36M 3.32M 2.61M
Net Income
402.1K -9.52M 2.77M 2.08M
Selling & General & Admin
18.52M 17.12M 15.58M 14.63M
Research & Development
1.24M 1.17M 384.79K 49.87K
Other Expenses
794.32K 16.92M 1.12M 834.85K
Operating Expenses
20.56M 35.21M 17.08M 15.51M
Interest Expense
1.86M 1.24M 1.52M 1.38M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
28.51M 43.65M 25.88M 24.5M
Income Tax Expense
2.4M -3.84M 547.54K 527.71K
Shares Outstanding (Basic)
8.13M 8.34M 8.47M 8.14M
Shares Outstanding (Diluted)
8.21M 8.34M 8.48M 8.36M
EPS (Basic)
0.05 -1.14 0.33 0.26
EPS (Diluted)
0.05 -1.14 0.33 0.25
EBITDA
1.42M -10.42M 6.65M 5.32M
EBIT
939.44K -12.13M 4.84M 3.99M
Depreciation & Amortization
483.52K 1.71M 1.81M 1.33M